Dr. Amal S. H. Al Omari, MS, PhD
Chief Scientific Officer
King Hussein Cancer Center
Dr. Amal Al Omari holds a PhD in Clinical Pharmaceutical Sciences from the University of Iowa, USA. She has more than 25 years of experience spanning pharmaceutical research and development, academia, oncology research and research administration.
In her capacity as the Chief Scientific Officer at King Hussein Cancer Center she reports to the Director General/Chief Executive Officer and leads the Office of Scientific Affairs & Research (OSAR); the main administrative body responsible for the management of all research operations at KHCC. OSAR hosts KHCC's hospital-based cancer Registry, the Center for Research Shared Resources (with a dedicated clinical trials unit) and the Center for Grants and Contracts Management. Dr. Al Omari is also responsible for review of institutional collaboration agreements, material transfer agreements, research grant agreements and all clinical trial contracts with CROs and pharmaceutical companies. Currently, she's also the Acting Chair of KHCC's Research Council.
Dr. Al Omari is a seasoned pharmacist and clinical researcher, with a wealth of knowledge and experience in clinical research management and quality operations. Her research interests are mainly related to the epidemiology of non-communicable diseases (NCDs), in particular oncologic malignancies in Middle Eastern populations, especially in Jordan, in addition to research exploring genetic and epidemiologic predictors of outcome to cancer treatment among Jordanians and other Middle Eastern populations. Dr. Al-Omari authored or co-authored many peer-reviewed publications in prestigious medical journals as well as book chapters. She serves as a reviewer for several reputable scientific journals.
Dr. Al Omari initiated a research quality assurance project at KHCC by establishing and implementing a comprehensive Human Research Protection Program. The program was awarded full AAHRPP accreditation in June 2019 and KHCC was the first institution in Jordan and among very few cancer centers worldwide to have this quality designation. She also oversees strategic networking with leading institutions at the regional and international level to promote and advance clinical research activities, increase patient access to clinical trials, as well as research training and capacity building.
